Samsara BioCapital, L.P. 13D and 13G filings for Kalaris Therapeutics Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-22 7:48 pm Sale | 2026-05-20 | 13D | KALARIS THERAPEUTICS INC KLRS | Samsara BioCapital, L.P. | 12,900,583 54.200% | -53,498 (-0.41%) | Filing |
| 2026-02-17 8:14 pm Purchase | 2025-12-18 | 13D | KALARIS THERAPEUTICS INC KLRS | Samsara BioCapital, L.P. | 12,954,081 56.500% | 500 (+0.00%) | Filing |
| 2025-12-22 4:17 pm Purchase | 2025-12-22 | 13D | KALARIS THERAPEUTICS INC KLRS | Samsara BioCapital, L.P. | 12,953,581 56.500% | 1,505,500 (+13.15%) | Filing |
| 2025-03-25 7:40 pm Purchase | 2025-03-18 | 13D | KALARIS THERAPEUTICS INC KLRS | Samsara BioCapital, L.P. | 11,448,081 61.200% | 11,448,081 (New Position) | Filing |